MTA1
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) |
| ||||||||
RefSeq (protein) |
| ||||||||
Location (UCSC) | Chr 14: 105.42 – 105.47 Mb | Chr 12: 113.06 – 113.1 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
Metastasis-associated protein MTA1 is a
Discovery
MTA1 was first cloned by Toh, Pencil and Nicholson in 1994 as a differentially expressed gene in a highly metastatic rat breast cancer cell line.[5][6] The role in MTA1 in chromatin remodeling was deduced due to the presence of MTA1 polypeptides in the NuRD complex.[8] The first direct target of the MTA1-NuRD complex was ERα.[14] MTA2 was initially recognized as MTA1-like 1 gene, named as MTA1-L1, as a randomly selected clone from a large-scale sequencing effort of human cDNAs by Takashi Tokino's laboratory. MTA2's suspected role in chromatin remodeling was inferred from the prevalence of MTA2 polypeptides with the NuRD complex in a proteomic study(Zhang et al., 1999, Kumar and Wang, 2016).
Gene and spliced variants
The MTA1 is 715/703 amino acids long, coded by one of three genes of the MTA family and localized on chromosome 14q32 in
Protein domains
The conserved domains of MTA1 include a BAH (Bromo-Adjacent Homology), an ELM2 (egl-27 and MTA1 homology), a SANT (SWI, ADA2, N-CoR, TFIIIB-B) and a GATA-like zinc finger. The C-terminal divergent region of MTA1 has an Src homology 3-binding domain, acidic regions, and nuclear localization signals. The presence of these domains revealed the role of MTA1 in interactions with modified or unmodified histone and non-histone proteins, chromatin remodeling, and modulation of gene transcription.[9][18][19][20] MTA1 undergoes multiple post-translation modifications: acetylation on lysine 626, ubiquitination on lysine 182 and lysine 626, sumoylation on lysine 509, and methylation on lysine 532.[21][22][23] The structural insights of MTA1 domains are deduced from studies involving complexes with HDAC1 or RbAp48 subunits of the NuRD complexes.[18][19] The MTA1s variant is an N-terminal portion of MTA1 without nuclear localization sequence but contains a novel sequence of 33 amino acids in its C-terminal region. The novel sequence harbors a nuclear receptor binding motif LXXLL which confers MTA1 with an ability to interact with estrogen receptor alpha or other type I nuclear receptors.[17] The ZG29p variant represents the c-terminal MTA1 with two proline-rich SH3 binding sites.[16][24]
Regulation
Expression of MTA1 is influenced by transcription and non-transcriptional mechanisms. MTA1 expression is regulated by growth factors, growth factor receptors, oncogenes, environmental stress, ionizing radiation, inflammation, and hypoxia.[9][12] The transcription of MTA1 is stimulated by transcriptional factors including, c-Myc,[25] SP1,[26] CUTL1 homeodomain,[27] NF-ḵB,[28] HSF1,[29] HIF-1a,[30] and Clock/BMAL1 complex,[31] and inhibited by p53.[32] Non-genomic mechanisms of MTA1 expression include post-transcriptional regulations such as ubiquitination by RING-finger ubiquitin-protein ligase COP1 [33] or interaction with tumor suppressor ARF [24] or micro-RNAs such as miR-30c, miR-661 and miR-125a-3p.[34][35][36][37]
Targets
Functions of MTA1 are regulated by its post-translational modifications, modulating the roles of effector molecules, interacting with other regulatory proteins and chromatin remodeling machinery, and modulating the expression of target genes via interacting with the components of the NuRD complex including HDACs.[9][18][19]
MTA1 suppresses transcription of breast cancer type 1 susceptibility gene,[38] PTEN,[39] p21WAF,[40] guanine nucleotide-binding protein G(i) subunit alpha-2,[21] SMAD family member 7,[41] nuclear receptor subfamily 4 group A member 1,[42] and homeobox protein SIX3,[43] and represses BCL11B[44] as well as E-cadherin expression.[45][46]
MTA1 is a dual coregulatory as it stimulates the transcription of Stat3,[47] breast cancer-amplified sequence 3,[48] FosB,[27] paired box gene 5,[49] transglutaminase 2,[50] myeloid differentiation primary response 88,[51] tumor suppressorp14/p19ARF,[26][52] tyrosine hydroxylase,[53] clock gene CRY1,[31] SUMO2,[22] and Wnt1 and rhodopsin due to release of their transcriptional inhibition by homeodomain protein Six3,[43][54]
MTA1 interacts with ERα and coregulatory factors such as MAT1,[55] MICoA,[56] NRIF3 [55][57] and LMO4, [56],[58] which inhibits ER transactivation activity.[14] MTA1 also deacetylate its target proteins such as p53 and HIF and modulates their transactivation functions.[59][60] Furthermore, MTA1 could potentially modulate the expression of target genes through the microRNA network as MTA1 knockdown results modulation of miR-210, miR-125b, miR-194, miR-103, and miR-500.[61][62]
Cellular functions
MTA1 modulates the expression of target genes due to its ability to act as a corepressor or coactivator. MTA1 targets and/or effector pathways regulate pathways with cellular functions in both normal and cancer cells.
Notes
PMID 26869315 . |
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000182979 - Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021144 - Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ PMID 8083195.
- ^ S2CID 17852701.
- S2CID 7959609.
- ^ PMID 9885572.
- ^ PMID 26093897.
- ISBN 978-981-281-917-8.
- ^ PMID 25344801.
- ^ PMID 25344802.
- PMID 25348751.
- ^ S2CID 23477845.
- ^ PMID 26869315.
- ^ PMID 10393810.
- ^ S2CID 4355677.
- ^ PMID 23791785.
- ^ PMID 24920672.
- PMID 25352341.
- ^ PMID 20651739.
- ^ PMID 21965678.
- PMID 23352453.
- PMID 10933808.
- PMID 16172399.
- ^ PMID 21555589.
- ^ PMID 21258411.
- PMID 22253283.
- S2CID 7056025.
- PMID 16511565.
- ^ PMID 24089055.
- PMID 19837670.
- PMID 19805145.
- PMID 25332146.
- PMID 24595016.
- PMID 19584269.
- PMID 25998575.
- PMID 17922032.
- PMID 22700976.
- PMID 20071335.
- PMID 22841502.
- S2CID 6726902.
- ^ PMID 20682799.
- PMID 16091750.
- PMID 24424621.
- PMID 18719363.
- PMID 23580571.
- PMID 16617102.
- PMID 17671180.
- PMID 21156794.
- PMID 20702415.
- ^ PMID 20505336.
- PMID 21368136.
- PMID 17666527.
- PMID 12527756.
- PMID 12639951.
- PMID 15254226.
- PMID 16288053.
- PMID 17914590.
- PMID 16969516.
- PMID 22576802.
- PMID 23718732.
- S2CID 2422645.
External links
- MTA1+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Overview of all the structural information available in the PDB for UniProt: Q13330 (Metastasis-associated protein MTA1) at the PDBe-KB.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.